Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)

Market Cap	4.16B +34.1%
Revenue (ttm)	336.73M +22.0%
Net Income	101.91M +49.3%
EPS	1.54 +47.4%
Shares Out	66.70M
PE Ratio	40.50
Forward PE	n/a
Dividend	0.60 (1.01%)
Ex-Dividend Date	May 30, 2025

Volume	1,784,733
Average Volume	941,800
Open	60.00
Previous Close	59.18
Day's Range	59.44 - 62.48
52-Week Range	41.40 - 92.50
Beta	-0.02
RSI	37.58
Earnings Date	Apr 28, 2026

About SHE:301033

Medprin Regenerative Medical Technologies Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical devices. The company offers artificial dura matermembrane patches, craniomaxillofacial repair and fixation systems, and absorbable regenerative oxidation for neurosurgery meningeal repair, skull repair fixation and rapid hemostasis, etc. It also offers ReDura, a Synthetic Dural Substitute; NeoDura, a novel dural patch; Recranio, a Cranio-Maxillofacial repair system; and StypCel, an Absorbable Hemostat; Immiseal,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 337
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301033

Financial Performance

In 2024, SHE:301033's revenue was 278.44 million, an increase of 20.61% compared to the previous year's 230.87 million. Earnings were 78.85 million, an increase of 92.90%.